Hengeler Mueller advises Elanco Animal Health on Bayer Animal Health Acquisition

Elanco
Animal Health Incorporated today announced it had entered into an agreement
with Bayer AG to acquire its animal health business in a transaction valued at
$7.6 billion. The transaction will be financed by a 70% cash/30% equity
combination.

Hengeler Mueller
advises Elanco on the acquisition together with Paul, Weiss, Rifkind, Wharton
& Garrison LLP (team is led by Tarun Stewart, New York). The Hengeler
Mueller team is led by partners Christian Möller and Maximilian Schiessl (both
M&A, Düsseldorf) and includes partners Hendrik Bockenheimer (Employment,
Frankfurt), Wolfgang Kellenter (IP, Düsseldorf), Matthias Scheifele (Tax,
München) and Dirk Uwer (Life Sciences / Public Law, Düsseldorf), counsel Markus
Ernst (Tax, München), Benedikt Migdal (IP, Düsseldorf), Eckbert Müller
(Employment, Frankfurt) and Ralf Willer (M&A, Berlin) as well as associates
Oda Goetzke, Marc Seeger, Tianyuan Zhuang, Johannes Fütterer, Benedikt Statz,
Alexander von Bernstorff (all Düsseldorf), Yenilee Ičagić (Berlin) (all
M&A), Susanne Koch (Life Sciences / Public Law), Julia Fischer, Norman
Koschmieder (both Public Law) (all Düsseldorf), Marius Mayer (Employment) and
Sebastian Heinrichs (Tax) (both Frankfurt).

More from Hengeler Mueller